MetaCap

COMPASS Pathways Plc American Depository Shares (CMPS) vs Kardigan (KARD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

COMPASS Pathways Plc American Depository Shares is the larger company by market cap ($1.14 billion vs $1.08 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CMPS-35.75%KARD-47.55%
+25%-13%-51%
Jun 18, 20261 yearNov 20, 2026
CMPS-35.75%KARD-47.55%
+25%-13%-51%
Jun 15, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CMPS versus KARD key metrics
MetricCMPSKARD
Share price$8.05$11.54
Market cap$1.14B$1.08B
1-day change-6.94%-7.83%
YTD return+16.67%—
1-year return+55.71%—
5-year return-75.42%—
EPS (TTM)$-2.34$-6.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-287.86M—
52-week high$15.87$27.00
52-week low$4.88$11.49
Distance from 52-week high-49.28%-57.26%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+189.57%+255.29%
Average volume3.09M625.83K
Shares outstanding141.71M93.60M
Employees156241
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About COMPASS Pathways Plc American Depository Shares

CMPS stock →

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.

Health Care · Biotechnology: Pharmaceutical Preparations · 156 employees

About Kardigan

KARD stock →

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees

CMPS vs KARD FAQ

Which is bigger, COMPASS Pathways Plc American Depository Shares or Kardigan?

COMPASS Pathways Plc American Depository Shares (CMPS) is larger, with a market capitalization of $1.14B compared with $1.08B for Kardigan (KARD).

Are COMPASS Pathways Plc American Depository Shares and Kardigan in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons